Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tracy BioConsulting is a private biopharmaceutical consulting firm that helps clients advance research-stage programs and platform technologies into and through clinical development. The company was founded by Mark A. Tracy, Ph.D., and focuses on product development, technical strategy, program management, regulatory support, and partnership guidance for biopharma clients. Its stated areas of expertise include RNA and other nucleic acid products, nanotechnology-based products, and protein, peptide, and small molecule therapeutics using novel delivery approaches. The firm works with a broad range of customers including large biopharma companies, emerging biotechnology companies, start-ups, CROs, CMOs, investors, and academic or research institutions. Rather than operating a proprietary therapeutic pipeline, Tracy BioConsulting functions as a specialized advisory partner to help external programs reach the clinic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tracy BioConsulting.